This bill amends the definition of medical cannabidiol in Iowa law by replacing the existing language in Section 124E.2, subsection 10. The new definition specifies that medical cannabidiol encompasses any species of the cannabis plant or its mixtures and preparations, including whole plant extracts and resins. It outlines the acceptable forms of delivery for medical cannabidiol, which are categorized into oral forms (such as tablets, capsules, liquids, tinctures, and sublingual forms), topical forms (including gels, ointments, creams, lotions, and transdermal patches), and inhaled forms (limited to nebulizable inhaled forms, vaporizable dried raw cannabis, and other vaporizable forms).

The bill aims to clarify and expand the types of medical cannabidiol that can be utilized within the state's medical program, ensuring that patients have access to a broader range of cannabis products for therapeutic use. The inclusion of specific delivery methods reflects a more comprehensive approach to the medical use of cannabis in Iowa.

Statutes affected:
Introduced: 124E.2